Your browser is no longer supported. Please, upgrade your browser.
AZRX AzurRx BioPharma, Inc. daily Stock Chart
AzurRx BioPharma, Inc.
Index- P/E- EPS (ttm)-0.66 Insider Own2.60% Shs Outstand26.94M Perf Week4.63%
Market Cap29.65M Forward P/E- EPS next Y-0.43 Insider Trans0.00% Shs Float25.50M Perf Month38.14%
Income-15.80M PEG- EPS next Q-0.11 Inst Own5.20% Short Float0.32% Perf Quarter27.31%
Sales- P/S- EPS this Y22.80% Inst Trans0.59% Short Ratio0.25 Perf Half Y21.01%
Book/sh0.11 P/B10.27 EPS next Y24.60% ROA-174.70% Target Price- Perf Year16.05%
Cash/sh0.06 P/C18.53 EPS next 5Y- ROE-457.10% 52W Range0.37 - 1.94 Perf YTD8.65%
Dividend- P/FCF- EPS past 5Y-22.50% ROI- 52W High-41.70% Beta2.05
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin- 52W Low204.69% ATR0.12
Employees10 Current Ratio0.60 Sales Q/Q- Oper. Margin- RSI (14)58.52 Volatility16.47% 11.42%
OptionableNo Debt/Eq1.10 EPS Q/Q25.80% Profit Margin- Rel Volume16.03 Prev Close1.03
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume325.21K Price1.13
Recom2.00 SMA2010.51% SMA5018.71% SMA20033.17% Volume5,211,835 Change9.88%
Jun-11-19Initiated National Securities Buy $9
Oct-17-18Initiated Oppenheimer Outperform $6
Jul-24-17Initiated H.C. Wainwright Buy $8
Aug-12-20 03:43PM  
Aug-11-20 04:01PM  
Aug-05-20 11:04AM  
Jul-27-20 05:22AM  
Jul-22-20 08:20AM  
Jul-21-20 08:00AM  
Jul-20-20 08:00AM  
Jun-01-20 05:45AM  
May-29-20 03:08PM  
May-07-20 08:00AM  
May-05-20 08:00AM  
May-04-20 06:45AM  
Apr-30-20 08:00AM  
Apr-29-20 08:00AM  
Apr-21-20 08:00AM  
Apr-20-20 08:00AM  
Apr-16-20 02:00PM  
Apr-15-20 08:00AM  
Apr-09-20 10:30AM  
Apr-01-20 12:00PM  
Mar-18-20 08:00AM  
Mar-02-20 08:00AM  
Feb-18-20 08:00AM  
Feb-03-20 10:10AM  
Jan-13-20 08:00AM  
Jan-12-20 05:05PM  
Jan-09-20 07:22PM  
Jan-06-20 08:00AM  
Jan-03-20 08:00AM  
Nov-26-19 11:35AM  
Nov-14-19 08:00AM  
Oct-22-19 08:00AM  
Oct-17-19 12:30PM  
Oct-15-19 07:30AM  
Oct-10-19 07:30AM  
Sep-27-19 08:30AM  
Sep-25-19 08:57AM  
Aug-28-19 01:15PM  
Aug-26-19 11:30AM  
Aug-13-19 07:00AM  
Jul-22-19 08:01PM  
Jul-17-19 11:35PM  
Jul-10-19 10:45AM  
Jul-08-19 04:03PM  
Jun-07-19 08:00AM  
May-28-19 08:22AM  
May-23-19 09:45AM  
May-20-19 02:30PM  
Apr-23-19 07:45AM  
Apr-11-19 10:00AM  
Apr-02-19 07:45AM  
Mar-18-19 07:45AM  
Mar-15-19 07:45AM  
Mar-12-19 07:45AM  
Feb-20-19 07:45AM  
Jan-21-19 11:52AM  
Dec-19-18 08:00AM  
Dec-12-18 08:00AM  
Dec-04-18 09:45AM  
Nov-01-18 07:30AM  
Oct-16-18 07:30AM  
Sep-24-18 03:45PM  
Aug-28-18 09:45AM  
Aug-01-18 08:30AM  
Jul-02-18 09:30AM  
Jun-29-18 08:30AM  
May-30-18 08:03AM  
May-02-18 11:15AM  
May-01-18 09:10AM  
Apr-30-18 04:15PM  
Apr-23-18 08:45AM  
Apr-18-18 07:45AM  
Apr-13-18 01:15PM  
Mar-02-18 09:00AM  
Feb-28-18 08:30AM  
Feb-12-18 08:15AM  
Feb-08-18 04:30PM  
Jan-30-18 09:00AM  
Jan-18-18 08:00AM  
Jan-16-18 11:16PM  
Dec-20-17 07:30AM  
Dec-04-17 07:00AM  
Dec-01-17 05:50PM  
Oct-20-17 08:30AM  
Oct-16-17 08:30AM  
Oct-11-17 03:54PM  
Sep-27-17 09:00AM  
AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. The company's therapeutic products are administered to patients as oral non-systemic biologics. Its lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency for cystic fibrosis and chronic pancreatitis patients. The company was incorporated in 2014 and is headquartered in Brooklyn, New York.